期刊文献+

托拉塞米与呋塞米对急性心力衰竭患者尿量及电解质影响比较 被引量:8

Comparison with effects of torasemide and furosemide on urine volume and electrolytes in patients with acute heart failure
暂未订购
导出
摘要 目的比较托拉塞米与呋塞米对急性心力衰竭患者尿量及电解质的影响。方法将149例急性心力衰竭患者随机分为4组:托拉塞米组(n=32),呋塞米组(n=41),托拉塞米+螺内酯组(n=30),呋塞米+螺内酯组(n=46),用药24小时,统计出入量,测定用药前后血钾和血钠浓度,对比分析各组患者尿量及血钠和血钾变化。结果①托拉塞米组和呋塞米组24小时尿量差异无统计学意义,(3 591.34±835.15)ml vs(3 525.22±842.51)ml(P>0.05);②托拉塞米组与呋塞米组对血钠影响差异无统计学意义,(2.24±0.97)mmol/L vs(2.29±1.05)mmol/L(P>0.05),托拉塞米+螺内酯组利钠作用最强(3.11±1.72)mmol/L,与托拉塞米组和呋塞米组比较差异均有统计学意义(P<0.01);③在排钾作用方面,托拉塞米+螺内酯组最小(0.09±0.05)mmol/L,而呋塞米组最大(0.25±0.32)mmol/L(P<0.01),托拉塞米组排钾小于呋塞米组(0.12±0.06)mmol/L(P<0.01)。结论托拉塞米与呋塞米利尿、排钠作用相近,而托拉塞米排钾作用明显弱于呋塞米,两者交替使用,有助于增加疗效,减少利尿剂抵抗的发生。 Objective To observe effects of torasemide and furosemide on the urine volume and electrolytes in the patients with acute heart failure. Methods Total 149 patients with acute heart failure were randomly divided into four groups : torasemide group( n = 32), furosemide group( n = 41), torasemide add spironolaetone group ( n = 30) and fruosemide add spironolactone group( n = 46). 24 hours after the drugs were used,the urine volume was recorded, and the serum natrium and potassium were detected. The changes of the items were analyzed. Results (1)There was no significant difference in the urine volume of 24 hours between torasemide group and furosemide group, (3 591.34± 835.15) ml vs (3 525.22 ± 842.51) ml( P 〉0.05). (2)In the effect of discharging natrium ion side, there was no significant discrepancy between torasemide group and furosemide group, (2.24± 0.97) mmol/L vs (2.29±1.05) mmol/L( P 〉0.05). Torasemide add spironolactone group was the most powerful in four groups(3.11±1.72) mmol/L( P 〈0.01). (3)In the effect of discharging potassium ion side,which was the most weak in torasemide add spironolactone group (0.09±0.05) mmol/L,and strongest in furosemide group(0.25±0.32) mmol/L ( P 〈0.01). The torasemide group was inferior to furosemide group in effect of discarging potassium (0.12 ± 0.06) mmol/L vs (0.25± 0.32) mmol/L ( P 〈 0.01). Conclusion It is similar between torsaemide and furosemide in the effect of diuresis and discharging natrium. The effect of torasemide keeping potassium is stronger than that of furosemide. Torsaemide and furosemide in alternate use,is helpful to increase therapeutic effect and decrease diuretic resistance.
出处 《临床荟萃》 CAS 2009年第15期1293-1295,共3页 Clinical Focus
关键词 心力衰竭 充血性 托拉塞米 呋塞米 heart failure, congestive torasemide ~ furosemide
  • 相关文献

参考文献11

  • 1Hunt SA, Baker DW, Chin MH, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary[J]. J Heart Lung Transplant, 2002,21(2) : 189-203.
  • 2Fortuno A, Muniz P, Ravassa S, et al. Torasemide inhibits angiotensin Ⅱ-induced vasoconstriction and intracellular calcium increase in the aorta of spontaneously hypertensive rats [J]. Hypertension, 1999,34 (1) : 138-43.
  • 3汪亚芸,陈曼华.托拉塞米短期治疗充血性心力衰竭的疗效观察[J].临床荟萃,2008,23(18):1352-1353. 被引量:8
  • 4Vasavada N, Saha C, Agarwal R. A double-blind randomized crossover trial of two loop diuretics in chronic kidney disease [J]. Kidney Int,2003,64(2):632-40.
  • 5Goodfriend TL, Ball DL, Oelkers W, et al. Torasemide inhibits aldosterone secretion in vitro[J]. Life Sci, 1998,63(3) : 45-50.
  • 6崔炜,郭艺芳.2008年心血管病学重要临床进展[J].临床荟萃,2009,24(5):375-380. 被引量:9
  • 7Cosin I,Diez J. Torasemide in chronic heart failure[J]. Eur J Heart Fail,2002,4(4) :507-513.
  • 8Cosin J, Diez J, TORIC investigators. Torasemide in chronic heart failure:results of the TORIC study[J]. Eur J Heart Fail, 2002,4(4) : 507-513.
  • 9Muller K,Gamba G,Jaquet F,et al. Torasemide vs. furosemide in primary care patients with chronic heart failure NYHA Ⅱ to Ⅳ-efficacy and quality of life[J]. Eur J Heart Fail,2003,5(6) 793-801.
  • 10谢瑞芹,崔炜.利尿剂在心血管疾病中的合理使用[J].临床荟萃,2008,23(10):698-700. 被引量:4

二级参考文献63

  • 1李一石,华潞,陈君柱,黄德嘉,黄洁,何建国,姚康宝,张健,蒋文,汪芳,苏绮,刘晗,成小如,康健,张阴凤.托拉塞米、呋噻米治疗慢性心力衰竭水肿的疗效和安全性比较研究[J].中国循环杂志,2004,19(4):290-293. 被引量:22
  • 2Parati G, Stergiou GS, Asmar R, et al. European Society of Hypertension guidelines for blood pressure monitoring at home:a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring [ J ]. J Hvoertens.2008,26(8) :1505-1526.
  • 3Beckett NS, Peters R, Fletcher AE, et al. Treatment of hypertension in patients 80 years of age or older[J]. N Engl J Med,2008,358(18) :1887-1898.
  • 4Jamerson K, Weber MA, Bakris GL, et al. Benazepril plus amlodipine or hydroehlorothiazide for hypertension in high-risk patients[J]. N Engl J Med,2008,359(23) ~2417-2428.
  • 5Yusuf S, Teo KK, Pogue J, et al. Telmisartan, ramipril, or both in patients at high risk for vascular events[J]. N Engl J Med, 2008,358(15) : 1547-1559.
  • 6Fox K, Ford I, Steg PG, et al. Ivabradine for patients with stable coronary artery disease and left-ventrieular systolic dysfunction (BEAUTIFUL) : a randomised, double-blind, placebo-controlled trial[J]. Lancet,2008,372(9641) :807-816.
  • 7Rouleau JL, Warnica WJ, Baillot R, et al. Effects of angiotensin-converting enzyme inhibition in low-risk patients early after coronary artery bypass surgery [J ]. Circulation, 2008,117(1) :24-31.
  • 8Bergman H,Rolink AM,Verheugt FW. Hotline sessions of the 30th European Congress of Cardiology[J]. Eur Heart J, 2008, 29(24) :3061-3064.
  • 9Collet JP, Silvain J, Landivier A, et al. Dose effect of clopidogrel reloading in patients already on 75-rag maintenance dose: the Reload with Clopidogrel Before Coronary Angioplasty in Subjects Treated Long Term with Dual Antiplatelet Therapy (RELOAD) study[J]. Circulation, 2008,118(12) : 1225-1233.
  • 10Stabile E,Nammas W,Salemme L,et al. The CIAO (Coronary Interventions Antiplatelet-based Only) Study: a randomized study comparing standard anticoagulation regimen to absence of anticoagulation for elective percutaneous coronary intervention[J]. J Am Coil Cardiol,2008,52(16) :1293-1298.

共引文献21

同被引文献57

引证文献8

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部